PMC:7600245 / 81828-82003 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7600245","sourcedb":"PMC","sourceid":"7600245","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7600245","text":"rombotic complications. Most frequently tested anti-inflammatory/immunomodulatory agents are listed in Table 2. Antithrombotic agents that are most frequently being tested in ","tracks":[{"project":"LitCovid-PD-CLO","denotations":[{"id":"T859","span":{"begin":40,"end":46},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T860","span":{"begin":165,"end":171},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"attributes":[{"subj":"T859","pred":"source","obj":"LitCovid-PD-CLO"},{"subj":"T860","pred":"source","obj":"LitCovid-PD-CLO"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T641","span":{"begin":24,"end":111},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T641","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PD-CLO","color":"#ec93c3","default":true},{"id":"LitCovid-sentences","color":"#93ddec"}]}]}}